These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10702954)

  • 1. [Interferon and plasma lipids].
    García-Escaño MD; Andrade RJ; González-Santos P
    Med Clin (Barc); 2000 Jan; 114(2):74-6. PubMed ID: 10702954
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of lipid metabolism in patients with chronic viral hepatitis treated with interferon alpha].
    Zejc-Bajsarowicz M; Cieśla A; Mach T; Janas-Skulina U; Warunek W; Zyrkowska-Bieda T
    Przegl Lek; 2005; 62(4):214-7. PubMed ID: 16229237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipid kinetics during dual antiviral therapy in patients with chronic hepatitis C].
    Jiménez Macías FM; Barrero Alor F; Casado Monge PG; Ramos Lora M; Pujol de la Llave E; Ruíz-Frutos C
    Med Clin (Barc); 2015 Jun; 144(12):536-43. PubMed ID: 24726260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hypertriglyceridaemia in a non-diabetic patient after alpha-interferon.
    Elisaf M; Tsianos EV
    Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):463. PubMed ID: 10321768
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on the paper 'The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study'.
    Loftis JM; Hauser P
    Hum Psychopharmacol; 2005 Apr; 20(3):211-2; author reply 213. PubMed ID: 15799008
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced hypertriglyceridemia with and without pancreatitis.
    Keung YK; Rizk R; Wu XY; Cobos E
    South Med J; 1999 Sep; 92(9):912-4. PubMed ID: 10498170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipid profile and chronic hepatitis C virus.
    Purnak T; Efe C; Beyazit Y; Ozaslan E
    Hepatology; 2011 Feb; 53(2):716-7. PubMed ID: 20890943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interferon in the treatment of viral hepatitis. The interferon was discovered 50 years ago].
    Fehér J; Lengyel G
    Orv Hetil; 2007 Aug; 148(33):1539-43. PubMed ID: 17686671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein changes in patients with chronic hepatitis C treated with interferon-alpha.
    Fernández-Miranda C; Castellano G; Guijarro C; Fernández I; Schöebel N; Larumbe S; Gómez-Izquierdo T; del Palacio A
    Am J Gastroenterol; 1998 Oct; 93(10):1901-4. PubMed ID: 9772052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype specific peripheral lipid profile changes with hepatitis C therapy.
    Pedersen MR; Patel A; Backstedt D; Choi M; Seetharam AB
    World J Gastroenterol; 2016 Dec; 22(46):10226-10231. PubMed ID: 28028371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Viral Hepat; 2011 Jul; 18(7):e263-9. PubMed ID: 21108701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C.
    Tahan V; Tahan G; Dane F; Uraz S; Yardim M
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):224-5. PubMed ID: 17592576
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute hepatitis C.
    Santantonio T
    Curr Pharm Des; 2004; 10(17):2077-80. PubMed ID: 15279546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Literature systematic review on the ophthalmological side effects of interferons.
    Fragoso YD; Paggiaro MS; Mastromauro R; Jacondino Gda S; Wilson HM
    Arq Bras Oftalmol; 2011; 74(4):306-10. PubMed ID: 22068863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon treatment in chronic HCV hepatitis and autoimmune hypothyroidism].
    Calvo Manuel E; Nieto Sánchez A; Espinos Pérez D
    An Med Interna; 2000 Mar; 17(3):164-5. PubMed ID: 10804649
    [No Abstract]   [Full Text] [Related]  

  • 16. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute pancreatitis during treatment for chronic viral hepatitis C].
    Kabbaj N; Sentissi S; Guedira MM; Mohammadi M; Benaïssa A; Amrani N
    Gastroenterol Clin Biol; 2008 Mar; 32(3):232-3. PubMed ID: 18378105
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients.
    Vasilij Benatti S; Giampaolo Q; Sara B; Marco R; Diego R
    AIDS; 2014 Nov; 28(17):2633-5. PubMed ID: 25574965
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute reversible rhabdomyolysis during interferon alpha2B therapy for hepatitis C.
    Gabrielli M; Santarelli L; Serricchio M; Leo D; Pola P; Gasbarrini A
    Am J Gastroenterol; 2003 Apr; 98(4):940. PubMed ID: 12738487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.